Senate Power Brokers Moving on Health Reform
WSJ Online
Fri, 11/7/08 - 10:16 am
Isis Technology Used to Attack Brain Tumors
Seeking Alpha
Fri, 11/7/08 - 10:14 am
Investors Liked What They Saw in Simcere's Q3 Report
Seeking Alpha
Fri, 11/7/08 - 10:13 am
Icagen posts loss on 75% revenue drop
Bizjournals.com
Fri, 11/7/08 - 10:12 am
Sanofi-Aventis cut to sell at UBS
Marketwatch
Fri, 11/7/08 - 09:59 am
PowerRatings Best of the Requests: GS, PFE, JNJ
Yahoo/Trading Markets
Fri, 11/7/08 - 09:57 am
Amgen to Review Business with Analysts
The Street.com
Fri, 11/7/08 - 09:55 am
Wyeth's Day In Court (WYE)
Investopedia
Fri, 11/7/08 - 09:54 am
Express Scripts, FBI, Probe Threat to Expose Records
Bloomberg
Fri, 11/7/08 - 09:52 am
Daiichi Sankyo Completes Purchase of 63.9% of Ranbaxy
Bloomberg
Fri, 11/7/08 - 09:47 am
Big Pharma’s Loss May Be Little Pharma’s Gain
Pharmalot
Thu, 11/6/08 - 09:52 am
Burrill: Biotech faces "a long down-turn"
Fierce Biotech
Thu, 11/6/08 - 09:52 am
A Byetta Beating
Motley Fool
Thu, 11/6/08 - 09:51 am
Vermont docs received more secret payments
Fierce Pharma
Thu, 11/6/08 - 09:49 am
SciClone's Phase III hepatitis trial fails endpoint
Trading Markets
Thu, 11/6/08 - 09:46 am
King Pharmaceuticals swings to third-quarter profit
Marketwatch
Thu, 11/6/08 - 09:28 am
CV Therapeutics says FDA approved Ranexa as first-line angina treatment, expanding uses
Yahoo/AP
Thu, 11/6/08 - 09:26 am
NeuroSearch's Gamble May Not Pay off After Acomplia Failure
Bloomberg
Thu, 11/6/08 - 09:25 am
AstraZeneca Pill May Gain $3 Billion, If Test Works
Bloomberg
Thu, 11/6/08 - 09:23 am
A.P. Pharma cuts 18 people, posts loss
Bizjournals.com
Thu, 11/6/08 - 09:22 am

Pages